Key Takeaways
- • Private equity and venture capital investment in global industrials reached US$82.06 billion through May 31, 2026, tracking toward a multiyear high of approximately US$165 billion if current pace continues—the strongest annual performance in at least six years.
- • US healthcare facility investment surged to US$12.52 billion in 2025, a spike of over 50 times the prior-year total of US$250 million, driven by two multibillion-dollar transactions despite deal volume declining to just 25 transactions (the lowest since at least 2021).
- • Data center expansion, post-pandemic global logistics reconfiguration, and elevated defense spending in response to geopolitical conflicts are primary catalysts fueling private capital deployment into industrials with tangible, hard assets.
- • Perceived artificial intelligence disruption risks in software and technology sectors are redirecting institutional capital toward industrial assets with physical infrastructure and demonstrated revenue streams, according to PwC's Michael Fiore.
Summary
Multiple structural factors are driving this capital reallocation. The data center buildout remains a primary investment thesis, as do supply chain modernization efforts in the post-pandemic environment and substantially increased defense spending triggered by ongoing conflicts in Ukraine and the Middle East. Michael Fiore, industrial products M&A leader at PwC, emphasized that industrial assets offer institutional investors tangible, physical collateral—"they're making products, they're shipping products. It's a hard asset. People can touch and feel it." This positioning appeals particularly to investors concerned about artificial intelligence disruption threatening software-centric business models and traditional valuation frameworks.
The US healthcare facility sector experienced even more dramatic activity in 2025, with private equity and venture capital investment reaching US$12.52 billion—a more than 50-fold increase from the prior year's US$250 million. However, this expansion masked underlying transaction consolidation: deal volume fell to just 25 transactions, the lowest annual count since at least 2021. The 2025 surge was concentrated in two substantial multibillion-dollar investments, indicating selective, high-value transaction focus rather than broad-based acquisition activity across the healthcare real estate landscape.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.